Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.

¥43.73As of Sun 8 Nov 2026, 12:00 UTC
SZSE:301096Healthcare
Country China
PE (Fwd) •••
TSR 5Y CAGR (12.54%)
Div yield —
ROE (3.62%)
Drug Manufacturers (General)
Beta (5Y) 0.54
PE TTM —
TSR TTM (24.47%)
Mkt cap ¥4.743B
ROIC (3.41%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥42
(4.70%)
(55.75%)
Hold 10|4|4|4|7
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.42
0.43
0.44
0.43
3.98%
9.87%
8.71%
10.17%
Revenue¥M
568.7
583.0
598.0
616.0
14.66%
11.22%
8.46%
5.63%
Peers (US$710.9M)
Cap (US$)
PE
663.9M
64.09x
619.8M
46.76x
805.5M
20.75x
Capital
TTM
5Y
10Y
Leveragex
1.526
0.026
0.020
EBIT/Intx
1.523
0.055
0.066
Own earn%
(230.78)
143.30
130.30
Sh yield%
28.09
45.93
44.91
Owners
Insiders/Inst%
1.88
48.94
Short interest%
5.53
SBC / revenue%
4.08
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
4–15
$1 testx
−0.2
Incr. ROIC%
2